Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Harry Herr

Showing results (1-10 of 65) with videos related to

Pageof 7
Sort By:
International Journal of Urology : Official Journal of the Japanese Urological Association|October 30, 2019
Does asymptomatic bacteriuria affect the response to intravesical bacillus Calmette-Guérin?Harry Herr
Urology Practice|June 10, 2023
Editorial CommentaryHarry Herr
European Urology|December 17, 2016
Re: Marko Babjuk, Andreas Böhle, Maximilian Burger, et al. EAU Guidelines on Non-muscle-invasive Urothelial Carcinoma of the Bladder: Update 2016. Eur Urol 2017;71:447-61Harry Herr
European Urology Focus|December 23, 2019
Urologic Principles Define the Standards for Successful Bladder Preservation in Muscle-invasive Bladder CancerHarry Herr
Urology Practice|June 15, 2023
Is Antibacterial Therapy Warranted before Outpatient Flexible Cystoscopy for Bladder Tumor Surveillance?Harry Herr
Urology Practice|March 11, 2025
Neoadjuvant Chemotherapy and Partial Cystectomy for Muscle-Invasive Bladder Cancer-20-Year Bladder-Preserved SurvivalHarry Herr
Urology|May 16, 2025
Intensive Intravesical BCG-Induction in Patients With Asymptomatic BacteriuriaHarry Herr
European Urology|January 13, 2026
Re: Oscar Buisan, Pol Servian, Sonia Pedreño-Lopez, et al. A Novel Heterologous Prime-boost Strategy Using RUTI Vaccine to Improve the Bacillus Calmette-Guérin Response in Non-muscle-invasive Bladder Cancer Patients: Phase 1 RUTIVAC-1 Trial. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2025.08.014Harry Herr
Urology|May 2, 2017
Pursuing Novel Ideas-Confessions of Lost Opportunities!Harry Herr
Urology|May 19, 2019
EDITORIAL COMMENTHarry Herr
Pageof 7

Showing results (1-10 of 65) with videos related to

Sort By:
Pageof 7
International Journal of Urology : Official Journal of the Japanese Urological Association|October 30, 2019
Does asymptomatic bacteriuria affect the response to intravesical bacillus Calmette-Guérin?Harry Herr
Urology Practice|June 10, 2023
Editorial CommentaryHarry Herr
European Urology|December 17, 2016
Re: Marko Babjuk, Andreas Böhle, Maximilian Burger, et al. EAU Guidelines on Non-muscle-invasive Urothelial Carcinoma of the Bladder: Update 2016. Eur Urol 2017;71:447-61Harry Herr
European Urology Focus|December 23, 2019
Urologic Principles Define the Standards for Successful Bladder Preservation in Muscle-invasive Bladder CancerHarry Herr
Urology Practice|June 15, 2023
Is Antibacterial Therapy Warranted before Outpatient Flexible Cystoscopy for Bladder Tumor Surveillance?Harry Herr
Urology Practice|March 11, 2025
Neoadjuvant Chemotherapy and Partial Cystectomy for Muscle-Invasive Bladder Cancer-20-Year Bladder-Preserved SurvivalHarry Herr
Urology|May 16, 2025
Intensive Intravesical BCG-Induction in Patients With Asymptomatic BacteriuriaHarry Herr
European Urology|January 13, 2026
Re: Oscar Buisan, Pol Servian, Sonia Pedreño-Lopez, et al. A Novel Heterologous Prime-boost Strategy Using RUTI Vaccine to Improve the Bacillus Calmette-Guérin Response in Non-muscle-invasive Bladder Cancer Patients: Phase 1 RUTIVAC-1 Trial. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2025.08.014Harry Herr
Urology|May 2, 2017
Pursuing Novel Ideas-Confessions of Lost Opportunities!Harry Herr
Urology|May 19, 2019
EDITORIAL COMMENTHarry Herr
Pageof 7